Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
…, A Turgeon, A Turner, W van Bentum-Puijk… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
The REMAP-CAP (randomized embedded multifactorial adaptive platform for community-acquired pneumonia) study. Rationale and design
…, F Al-Beidh, Y Arabi, W van Bentum-Puijk… - Annals of the …, 2020 - atsjournals.org
There is broad interest in improved methods to generate robust evidence regarding best
practice, especially in settings where patient conditions are heterogenous and require multiple …
practice, especially in settings where patient conditions are heterogenous and require multiple …
[HTML][HTML] A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
…, L Colle, F Kloosterman, W van Bentum-Puijk… - Clinical microbiology …, 2019 - Elsevier
Objectives Intestinal carriage with extended spectrum β-lactamase Enterobacteriaceae (ESBL-E)
and carbapenemase-producing Enterobacteriaceae (CPE) can persist for months. We …
and carbapenemase-producing Enterobacteriaceae (CPE) can persist for months. We …
[HTML][HTML] Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial
Interventions Patients were randomized to receive either open-label aspirin (n= 565), a
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …
Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19.
IMPORTANCE: The efficacy of antiplatelet therapy in critically ill patients with COVID-19 is
uncertain. OBJECTIVE: To determine whether antiplatelet therapy improves outcomes for …
uncertain. OBJECTIVE: To determine whether antiplatelet therapy improves outcomes for …
IL-6 receptor antagonist therapy for patients hospitalized for COVID-19: who, when, and how?
MA Matthay, AF Luetkemeyer - JAMA, 2021 - jamanetwork.com
(IL-6), based on the hypothesis that SARS-CoV-2 creates injury to the lung and other organs
in part through activation of cytokine and downstream proinflammatory networks. While …
in part through activation of cytokine and downstream proinflammatory networks. While …
[HTML][HTML] Simvastatin in critically ill patients with Covid-19
REMAP-CAP Investigators - New England Journal of Medicine, 2023 - Mass Medical Soc
Background The efficacy of simvastatin in critically ill patients with coronavirus disease 2019
(Covid-19) is unclear. Methods In an ongoing international, multifactorial, adaptive platform, …
(Covid-19) is unclear. Methods In an ongoing international, multifactorial, adaptive platform, …
[HTML][HTML] Continuation of therapeutic dose heparin for critically ill patients with COVID-19
CA Bradbury, PR Lawler, BJ McVerry… - Intensive care …, 2023 - Springer
Randomized trials demonstrated improved clinical outcomes when therapeutic-dose heparin
is administered to non-critically ill patients hospitalized for coronavirus disease 2019 (…
is administered to non-critically ill patients hospitalized for coronavirus disease 2019 (…
